June 26, 2020
PAR-18-665 - NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44 Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke (NINDS)
The purpose of this notice is to inform interested applicants of a change to the Key Dates for PAR-18-665 "NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44 Clinical Trial Optional)". This Funding Opportunity Announcement has been extended by one additional council round. The dates have been modified to add the following New Application Due Date:April 5, 2021. Changes are shown below in bold italics.
Currently Reads:
Part 1. Overview
Key Dates:
Application Due Date(s) |
April 16th thenStandard datesapply , by 5:00 PM local time of applicant organization. *** Note new SBIR/STTR Standard Due Dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
Scientific Merit Review | Standard datesapply |
Advisory Council Review | Standard datesapply |
Earliest Start Date | Standard datesapply |
Expiration Date | January 6, 2021 |
Modified to Read:
Part 1. Overview
Key Dates:
Application Due Date(s) |
April 16th thenStandard datesapply , by 5:00 PM local time of applicant organization. *** Note new SBIR/STTR Standard Due Dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
Scientific Merit Review | Standard datesapply |
Advisory Council Review | Standard datesapply |
Earliest Start Date | Standard datesapply |
Expiration Date | April 6, 2021 |
All other aspects of this FOA remain unchanged.
Emily Caporello, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1778
Email:Emily.caporello@nih.gov